Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Download the PDF here.
This post appeared first on investingnews.com
You May Also Like
Stock
In this market update, Frank breaks down recent developments across the S&P 500, crypto markets, commodities, and international ETFs. He analyzes bullish and bearish...
Stock
In this video, Dave shares his weekly stock scan strategy used to identify bullish stock trends. He illustrates how to set up this powerful...
Business
Peloton on Tuesday launched its own marketplace for reselling used equipment and gear as the company looks to capitalize on the many bikes and...
Business
OpenAI on Wednesday announced that it now has 3 million paying business users, up from the 2 million it reported in February. The San...